Eli Lilly Corp. buy UBS Group AG
Start price
20.10.23
/
50%
€557.00
Target price
20.10.24
€670.67
Performance (%)
51.40%
End price
21.10.24
€843.30
Summary
This prediction ended on 21.10.24 with a price of €843.30. The BUY prediction by UBS_Group_AG for Eli Lilly Corp. saw massive gains of 51.40%. UBS_Group_AG has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. Dividends of €4.63 are taken into consideration when calculating the performance. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eli Lilly Corp. | -9.042% | -9.042% | 1.043% |
| iShares Core DAX® | -4,93 % | -11,98 % | -3,67 % |
| iShares Nasdaq 100 | -2,63 % | -2,22 % | 14,64 % |
| iShares Nikkei 225® | -4,73 % | -10,90 % | 19,74 % |
| iShares S&P 500 | -2,54 % | -3,54 % | 9,34 % |
Comments by UBS_Group_AG for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its "buy" rating re-affirmed by analysts at UBS Group AG. They now have a $710.00 price target on the stock, up previously from $612.00.
Ratings data for LLY provided by MarketBeat
In the thread Trading Eli Lilly Corp.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€537.70
08.08.25
08.08.25
€767.46
08.08.26
08.08.26
45.92%
20.03.26
20.03.26
Stopped prediction by UBS_Group_AG for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€397.00
24.05.23
24.05.23
€462.89
24.05.24
24.05.24
88.34%
25.05.24
25.05.24